Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin flexible dose in peripheral neuropathic pain
NCT00141219Phase 3Completed
- Sponsor
- Viatris
- Start
- Dec 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Peripheral neuropathic pain comparing Pregabalin with Placebo (2 arms). Primary endpoint: Daily Pain Rating Scale - Mean Pain Score at Week 8. Started Dec 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT00141219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141219.